Phase II Study of Photodynamic Therapy With WST09 in Patients With Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure - Repeat Procedure
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2010
At a glance
- Drugs Padeliporfin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 01 Jun 2010 Status changed from discontinued to completed as reported by ClinicalTrials.gov.